When.com Web Search

  1. Ads

    related to: daratumumab mode of action
    • About DARZALEX®

      Learn About a Treatment Method and

      How DARZALEX® Works

    • For Caregivers

      Learn More About How You Can Help

      Your Loved One Throughout Treatment

Search results

  1. Results From The WOW.Com Content Network
  2. Daratumumab - Wikipedia

    en.wikipedia.org/wiki/Daratumumab

    Daratumumab, sold under the brand name Darzalex among others, ... Mechanism of action. Daratumumab is an IgG1k monoclonal antibody directed against CD38. CD38 is ...

  3. Daratumumab/hyaluronidase - Wikipedia

    en.wikipedia.org/wiki/Daratumumab/hyaluronidase

    It was approved for use in the United States in May 2020. [2] [7] [8]Efficacy of daratumumab and hyaluronidase-fihji (monotherapy) was evaluated in the COLUMBA trial (NCT03277105), an open-label non-inferiority trial randomizing 263 participants to daratumumab and hyaluronidase-fihj and 259 to intravenous daratumumab (daratumumab IV). [2]

  4. Isatuximab - Wikipedia

    en.wikipedia.org/wiki/Isatuximab

    Isatuximab, sold under the brand name Sarclisa, is a monoclonal antibody (mAb) medication for the treatment of multiple myeloma. [6] [4]The most common side effects include neutropenia (low levels of neutrophils, a type of white blood cell), infusion reactions, pneumonia (infection of the lungs), upper respiratory tract infection (such as nose and throat infections), diarrhoea and bronchitis ...

  5. Genmab Announces Net Sales of DARZALEX® (daratumumab) for 2024

    lite.aol.com/tech/story/0022/20250122/1001044358.htm

    COPENHAGEN, Denmark; January 22, 2025 – Genmab A/S (Nasdaq: GMAB) announced today that worldwide net trade sales of DARZALEX (daratumumab), including sales of the subcutaneous (SC) product (daratumumab and hyaluronidase-fihj, sold under the tradename DARZALEX FASPRO ® in the U.S.), as reported by J&J were USD 11,670 million in 2024.

  6. FDA approves new pain medication as an alternative to opioids ...

    www.aol.com/fda-approves-pain-medication...

    "This action and the agency’s designations to expedite the drug’s development and review underscore FDA’s commitment to approving safe and effective alternatives to opioids for pain ...

  7. Taking This Daily Vitamin Could Slash Dementia Risk By 40% ...

    www.aol.com/taking-daily-vitamin-could-slash...

    This is “the same mechanism targeted by new prescription drugs in Alzheimer’s disease,” he says. Vitamin D might also slow the buildup of tau tangles, which are another hallmark of Alzheimer ...

  1. Ads

    related to: daratumumab mode of action